Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer
Clinical trial NCT05296577 · UNKNOWN
Trial details
- NCT number
- NCT05296577
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-22
- Primary completion
- 2024-09-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.